Worldwide dispatch from Hong Kong · orders reserved 24 h · dispatched within 2 business daysAccountOrdersUSD

Octreotide

Peptide · Sequence Library

Buy Octreotide for research use from Seqvanta. Choose from 3 published package presentations and review the published presentation before checkout.

Offer
Published USD offer
Options
3 package options
Intended use
Research use only
Product photograph coming soon

Choose your package

Pick the package size that fits your order

Octreotide has 3 published package options. Select the row that matches your requested amount; each price is per package.

Select a package3 options
Your selection
1 mg$78.00 per package
1–999 packages

At a glance

Package details

Variant
human

Before you order

About Octreotide

Buy Octreotide for research use from Seqvanta. Package prices run from $78.00-$1,170.00 USD per package across 3 published package presentations; package content is 1 mg, 5 mg, 25 mg. Choose the presentation that matches your request, then review quality and shipping notes before checkout.

Product overview

What you’re buying

Peptide · The page keeps the named peptide separate from sequence, purity and clinical claims.

Identity

What Octreotide refers to

Octreotide has a published catalog identity. Use the identity note below with the receiving brief; the name alone does not establish equivalence.

Canonical name
Octreotide
Catalog class
Sequence-based material
Catalog category
Sequence Library
Identity status
Catalog identity published
Material context
research material; catalog identity published

Before you order

Make sure the listing matches your method

Use this section to match Octreotide to the protocol and receiving requirements; the catalog class does not establish sequence, purity, efficacy, approval, or human-use suitability.

  • Confirm sequence, length, modifications and batch documents when your method needs them.
  • Match the canonical Octreotide product to the protocol or purchase request before comparing offers.
  • Use the package fields and price as the purchasing boundary.

Published research

What researchers have studied

Research foundChecked 2026-09-13

Indexed PubMed records were found for this product name or a registered alias. They are research references, not proof that a specific batch is equivalent or clinically effective.

2026Human study

Assessment of Neuroendocrine Features Using 99mTc-Octreotide Scintigraphy in Patients with Metastatic Castration-Resistant Prostate Cancer: Does it Predict Response to 177Lu-PSMA Radioligand Therapy?

Indexed human study; review the original publication for its design, population and outcomes.

Human publication; review the study design and population before drawing conclusions.

Read the paper
2026Human study

Impact of Duration of Intravenous Octreotide Infusion on Achieving Hemostasis in Patients With Acute Variceal Hemorrhage.

Indexed human study; review the original publication for its design, population and outcomes.

Human publication; review the study design and population before drawing conclusions.

Read the paper
2026Cell study

A long-acting octreotide analog formed by conjugation with a peptide linker modified with two fatty acids.

Indexed cell or in-vitro study; findings do not establish human safety or efficacy.

Cell or in-vitro model; findings do not establish human efficacy or safety.

Read the paper
2026Review

Octreotide Administration Methods in Sulfonylurea Poisoning: A Retrospective Chart Review.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
2026Review

Octreotide as A Bridge to Anti-TNF Therapy in Severe Fistulizing Crohn's Disease Complicated by A Clinically High-Output Enterocutaneous Fistula: A Case Report and Literature Review.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
2026Research record

Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.

Indexed publication linked to this name; verify the exact compound and model in the full paper.

Model type was not explicit in the indexed record; verify the primary paper.

Read the paper
How to read this: ClinicalTrials.gov returned 58 matching registered record(s); registration is not the same as a published result. The studies are context for research procurement, not a promise of safety, dosing or benefit.

Documents and checks

What is published — and what to request

The details are grouped by the decision they support. Prices and package choices stay in the purchase panel above.

Documentation available for Octreotide

For Octreotide, verify identity, package presentation, and the analytical evidence required by the receiving method against a batch or analytical document that matches the receiving method. A lot-specific certificate of analysis is not published for Octreotide; request the required evidence before payment.

Public package fields
content and additional presentation fields
Evidence request
Request required batch or analytical documents before payment
SDS / safety data sheet
Not published on this page; request document
CAS number
Not published in the public catalog; request document
Concentration
Not published in the selected package rows; request document
Species reactivity
Not published in the public catalog; request method-specific document
Authenticity / chain of custody
No independent verification is published; request batch traceability documentation
Supplier reviews / rating
No public supplier reviews or rating are published
  • The public page shows the sequence-based material identity, package presentation, and current USD amount for Octreotide where available.
  • A lot-specific certificate of analysis and independent laboratory result are not published for Octreotide; request the batch or analytical documents required by the receiving process.
  • For this identity, package presentation, and the analytical evidence required by the receiving method check, an absent value stays a document request rather than a claim inferred from the product name.
Handling questions to resolve for Octreotide

The active catalog does not publish form-specific storage, shelf-life, transport, or stability specifications for Octreotide. Keep handling decisions with your laboratory's requirements and contact Seqvanta before ordering if storage, cold-chain, or stability evidence is a release requirement.

Storage specification
Not published in the public catalog
Shelf-life / stability
Not published in the public catalog
Transport / cold chain
Not published in the public catalog
  • Storage specification for Octreotide: Not published in the public catalog.
  • Shelf-life and stability: Not published in the public catalog.
  • Transport or cold-chain requirement: Not published in the public catalog.
  • Keep release decisions with the receiving laboratory SOP and confirm any product-specific requirement before ordering.
Quality specifications to verify for Octreotide

A research-grade or purity decision for Octreotide needs evidence that matches the receiving method. The public page does not turn an absent purity, bioactivity, endotoxin, or grade value into a claim; resolve the identity, package presentation, and the analytical evidence required by the receiving method questions before relying on this product.

Public purity / grade value
Not published in the public catalog
Public analytical result
Not published on this page; request the relevant document
Evidence request
Request the method, acceptance criteria, and batch document before payment
  • For Octreotide, the useful quality check is identity, package presentation, and the analytical evidence required by the receiving method.
  • A numeric purity, research-grade, bioactivity, or endotoxin value is not published in the public catalog unless it appears in the selected presentation or a document supplied for review.
  • Ask for the method, acceptance criteria, and batch traceability your receiving process requires; a product name is not a test result.
How to evaluate a source for Octreotide

For Octreotide, supplier evaluation means checking the identity evidence and traceability required by the receiving process. Commercial dispatch and reservation terms are listed separately.

Seller shown to buyers
Seqvanta
Public review score
Not published in the public catalog
Independent verification
Not claimed on this page
Evaluation basis
Identity, presentation, documentation, and traceability evidence
  • Evaluate the Octreotide source against canonical identity and package presentation; a product name alone is not a supplier assessment.
  • Check whether the documentation and traceability meet the receiving process.
  • Use public reviews only as supplementary context; no independent supplier score is published here.
More product details

Technical specifications published for Octreotide

The technical view for Octreotide covers identity fields that are not repeated in the package offer. Missing molecular or analytical values stay unconfirmed until the relevant listing or document supplies them.

Catalog classification
research material
Identity-linked technical fields
CAS, sequence, molecular weight, composition, and INCI: not published in the public catalog
Additional fields
Sequence or variant: human
  • Use Octreotide's canonical name when a method requires a technical identity check.
  • CAS, sequence, molecular weight, composition, and INCI details are not published in the public catalog unless explicitly listed in the identity section.
  • Keep package amount and presentation decisions with the offer rows above; do not infer a concentration or dose from a label.

How Octreotide is supplied

For Octreotide, Seqvanta's operational terms are a 24-hour reservation and dispatch within two business days after confirmed payment.

Seller
Seqvanta
How to order
Select a priced package above and continue to checkout.
Dispatch
Within two business days after confirmed payment
Reservation
24 hours after order creation

What this page can and cannot confirm

Octreotide confirms the catalog identity, package state, and checkout state: a priced package can be selected now. Primary literature, laboratory release criteria, and destination-country review remain separate.

Catalog vs checkout
Currently purchasable in checkout: priced package offers are published
Missing values
Not published in the public catalog
  • Catalog evidence: the name, package fields, and price state shown on this page.
  • Product classification and identity notes are shown where the catalog has a supported match.
  • Unrecorded fields remain not published in the public catalog and should be confirmed before a method depends on them.
  • This is a research-use procurement page, not a treatment, dosing, or human-use guide.

Questions before checkout

Short answers to practical questions

Answers focus on choosing, verifying and ordering this product.

What is Octreotide?

Octreotide is listed as a sequence-based material in the Sequence Library catalog. The identity status is catalog identity published; use the published name and package fields rather than extending the page into a sequence, purity, efficacy, or regulatory claim.

Which Octreotide package should I choose?

Choose the Octreotide row by total content (1 mg, 5 mg, and 25 mg); confirm the selected row in the cart before payment. A larger package price is not automatically a different formulation.

What should be confirmed before ordering Octreotide?

For Octreotide, use the canonical name, package row, and published evidence boundary together. The page supports a sourcing decision; treatment, dosing, and efficacy questions require separate sources.

What exactly is included in a Octreotide package?

Use the package comparison above for Octreotide: the selectable rows are 1 mg, 5 mg, and 25 mg. They show content and additional presentation fields on a mg basis; any unpublished field remains unconfirmed for the selected presentation.

What quality information is published for Octreotide?

The public product page shows the fields that are available for Octreotide; any missing SDS, CAS, concentration, or batch document must be requested before payment.

More questions about this product
How much does Octreotide cost?

Octreotide has a current published price of $78.00-$1,170.00 USD per package. Use the package table for the exact row amount; prices are per package, not a concentration or dose.

Is Octreotide currently purchasable or catalog-only?

Octreotide is an active catalog product and currently purchasable: the priced package rows above can be selected in checkout.

Is an SDS, CAS number, or concentration published for Octreotide?

SDS / safety data sheet, CAS number, and concentration for Octreotide are not published on the public product page unless a selected row states one. Request the relevant document before payment; do not infer these values from the name or package label.

Is species reactivity or authenticity verified for Octreotide?

Species reactivity and authenticity / chain-of-custody verification are not published for Octreotide. Request method-specific or batch traceability documentation when your receiving process requires it.

Does Seqvanta publish reviews or a supplier rating for Octreotide?

No public supplier reviews or rating are published for Octreotide. Evaluate the product against its identity evidence, documentation, and written fulfillment terms.

Commercial terms

Ordering terms

Review the package, reservation, and dispatch terms before checkout.

Minimum order
$100 merchandise subtotal.
Order reservation
24 hours after an order is created.
Dispatch
Within 2 business days after confirmed payment.

Contact Seqvanta

Questions about Octreotide?

Need to confirm the Octreotide package, documents, or delivery? Send the product name and package label through Contact. Use Wholesale for volume or private-label requests.

Contact us